News

European patent approval for UV1 – 25.06.2019

News

Technology

Ultimovacs is developing a universal cancer vaccine applicable across a broad spectrum of cancer types.

Technology

Clinical studies

Lead product tested in three clinical trials, strong results justifies the initiation of a registration trial.

Clinical studies